{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:55:03Z","timestamp":1794851703560,"version":"4.9.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1111\/bjd.13626","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T09:20:14Z","timestamp":1418980814000},"page":"1498-1506","source":"Crossref","is-referenced-by-count":67,"title":["Skin cancer risk in<i>BRCA1\/2<\/i>mutation carriers"],"prefix":"10.1093","volume":"172","author":[{"given":"P.V.","family":"Gumaste","sequence":"first","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology; New York University School of Medicine; New York NY U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Penn","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology; New York University School of Medicine; New York NY U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Cymerman","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology; New York University School of Medicine; New York NY U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kirchhoff","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Environmental Medicine; New York University School of Medicine; New York NY U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Polsky","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology; New York University School of Medicine; New York NY U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"McLellan","sequence":"additional","affiliation":[{"name":"The Ronald O. Perelman Department of Dermatology; New York University School of Medicine; New York NY U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"10.1111\/bjd.13626-BIB0001|bjd13626-cit-0001","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1111\/bjd.13626-BIB0002|bjd13626-cit-0002","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1541-7786.MCR-05-0192","article-title":"The role of the BRCA1 tumor suppressor in DNA double-strand break repair","volume":"3","author":"Zhang","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1111\/bjd.13626-BIB0003|bjd13626-cit-0003","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","article-title":"Brca1 controls homology-directed DNA repair","volume":"4","author":"Moynahan","year":"1999","journal-title":"Mol Cell"},{"key":"10.1111\/bjd.13626-BIB0004|bjd13626-cit-0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1097-2765(01)00174-5","article-title":"BRCA2 is required for homology-directed repair of chromosomal breaks","volume":"7","author":"Moynahan","year":"2001","journal-title":"Mol Cell"},{"key":"10.1111\/bjd.13626-BIB0005|bjd13626-cit-0005","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1093\/emboj\/20.17.4704","article-title":"Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences","volume":"20","author":"Tutt","year":"2001","journal-title":"EMBO J"},{"key":"10.1111\/bjd.13626-BIB0006|bjd13626-cit-0006","doi-asserted-by":"crossref","first-page":"8644","DOI":"10.1073\/pnas.151253498","article-title":"Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining","volume":"98","author":"Xia","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/bjd.13626-BIB0007|bjd13626-cit-0007","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1038\/sj.onc.1203334","article-title":"BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene","volume":"18","author":"Snouwaert","year":"1999","journal-title":"Oncogene"},{"key":"10.1111\/bjd.13626-BIB0008|bjd13626-cit-0008","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/MCB.21.10.3445-3450.2001","article-title":"Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation","volume":"21","author":"Xu","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1111\/bjd.13626-BIB0009|bjd13626-cit-0009","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/bjd.13626-BIB0010|bjd13626-cit-0010","doi-asserted-by":"crossref","first-page":"31941","DOI":"10.1074\/jbc.272.51.31941","article-title":"RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.13626-BIB0011|bjd13626-cit-0011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10549-012-2158-6","article-title":"Systemic therapy options in BRCA mutation-associated breast cancer","volume":"135","author":"Bayraktar","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/bjd.13626-BIB0012|bjd13626-cit-0012","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-13-523","article-title":"BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer","volume":"13","author":"Jacot","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1111\/bjd.13626-BIB0013|bjd13626-cit-0013","first-page":"3445","article-title":"Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype\/phenotype features with familial breast carcinomas","volume":"30","author":"Rhiem","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1111\/bjd.13626-BIB0014|bjd13626-cit-0014","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet"},{"key":"10.1111\/bjd.13626-BIB0015|bjd13626-cit-0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1111\/bjd.13626-BIB0016|bjd13626-cit-0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","article-title":"Assessing BRCA carrier probabilities in extended families","volume":"24","author":"Barcenas","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.13626-BIB0017|bjd13626-cit-0017","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/bjd.13626-BIB0018|bjd13626-cit-0018","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1111\/bjd.13626-BIB0019|bjd13626-cit-0019","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer","volume":"60","author":"Whittemore","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1111\/bjd.13626-BIB0020|bjd13626-cit-0020","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.2078.13.12","article-title":"Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites","volume":"13","author":"Whittemore","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/bjd.13626-BIB0021|bjd13626-cit-0021","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group","volume":"83","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.13626-BIB0022|bjd13626-cit-0022","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.13626-BIB0023|bjd13626-cit-0023","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"The Breast Cancer Linkage Consortium","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.13626-BIB0024|bjd13626-cit-0024","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-03-0604","article-title":"BRCA mutations and risk of prostate cancer in Ashkenazi Jews","volume":"10","author":"Kirchhoff","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.13626-BIB0025|bjd13626-cit-0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djj012","article-title":"Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000","volume":"98","author":"Tryggvadottir","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.13626-BIB0026|bjd13626-cit-0026","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1158\/0008-5472.CAN-08-0599","article-title":"The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families","volume":"68","author":"Palma","year":"2008","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.13626-BIB0027|bjd13626-cit-0027","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1054\/bjoc.2000.1626","article-title":"A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families","volume":"84","author":"Vahteristo","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.13626-BIB0028|bjd13626-cit-0028","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1186\/bcr632","article-title":"Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status","volume":"5","author":"Loman","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1111\/bjd.13626-BIB0029|bjd13626-cit-0029","first-page":"4259","article-title":"BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers","volume":"6","author":"Shih","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.13626-BIB0030|bjd13626-cit-0030","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0959-8049(99)00135-5","article-title":"Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers","volume":"35","author":"Johannsson","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.13626-BIB0031|bjd13626-cit-0031","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10689-010-9377-y","article-title":"BRCA1 and BRCA2 families and the risk of skin cancer","volume":"9","author":"Ginsburg","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1111\/bjd.13626-BIB0032|bjd13626-cit-0032","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4161\/cbt.4.12.2378","article-title":"Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers","volume":"4","author":"Navaraj","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/bjd.13626-BIB0033|bjd13626-cit-0033","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1111\/bjd.13626-BIB0034|bjd13626-cit-0034","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.13626-BIB0035|bjd13626-cit-0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","article-title":"Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations","volume":"11","author":"Moran","year":"2012","journal-title":"Fam Cancer"},{"key":"10.1111\/bjd.13626-BIB0036|bjd13626-cit-0036","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1111\/bjd.13626-BIB0037|bjd13626-cit-0037","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"Asperen","year":"2005","journal-title":"J Med Genet"},{"key":"10.1111\/bjd.13626-BIB0038|bjd13626-cit-0038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10689-008-9206-8","article-title":"Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin","volume":"8","author":"Kadouri","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1111\/bjd.13626-BIB0039|bjd13626-cit-0039","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","article-title":"On the use of familial aggregation in population-based case probands for calculating penetrance","volume":"94","author":"Begg","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.13626-BIB0040|bjd13626-cit-0040","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/94.18.1344","article-title":"Cancer risks in BRCA1 carriers: time for the next generation of studies","volume":"94","author":"Gruber","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.13626-BIB0041|bjd13626-cit-0041","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0959-8049(93)90013-6","article-title":"Second primary neoplasms following breast cancer in Saarland, Germany, 1968-1987","volume":"29A","author":"Brenner","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.13626-BIB0042|bjd13626-cit-0042","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/annonc\/mdg028","article-title":"Cancer risk in women with previous breast cancer","volume":"14","author":"Levi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.13626-BIB0043|bjd13626-cit-0043","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1023\/A:1018487506546","article-title":"Second primary cancers in breast cancer patients in Slovenia","volume":"8","author":"Volk","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1111\/bjd.13626-BIB0044|bjd13626-cit-0044","first-page":"99","article-title":"Second cancer following cancer of the breast in Connecticut, 1935-82","volume":"68","author":"Harvey","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1111\/bjd.13626-BIB0045|bjd13626-cit-0045","first-page":"325","article-title":"Second cancer following cancer of the female breast in Denmark, 1943-80","volume":"68","author":"Ewertz","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1111\/bjd.13626-BIB0046|bjd13626-cit-0046","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0360-3016(01)02661-X","article-title":"Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer","volume":"52","author":"Galper","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/bjd.13626-BIB0047|bjd13626-cit-0047","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/ijc.21651","article-title":"Risk of second cancer among women with breast cancer","volume":"118","author":"Mellemkjaer","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.13626-BIB0048|bjd13626-cit-0048","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11845-009-0297-5","article-title":"Malignant melanoma and breast\u00a0carcinoma: a bidirectional correlation","volume":"180","author":"Ho","year":"2011","journal-title":"Ir J Med Sci"},{"key":"10.1111\/bjd.13626-BIB0049|bjd13626-cit-0049","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1006489918700","article-title":"Increased risk of second cancers following breast cancer: role of the initial treatment","volume":"61","author":"Rubino","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/bjd.13626-BIB0050|bjd13626-cit-0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jso.2930070305","article-title":"Malignant melanoma and carcinoma of the breast","volume":"7","author":"Lokich","year":"1975","journal-title":"J Surg Oncol"},{"key":"10.1111\/bjd.13626-BIB0051|bjd13626-cit-0051","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejca.2007.10.006","article-title":"Common variants of DNA\u00a0repair genes and malignant melanoma","volume":"44","author":"Debniak","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.13626-BIB0052|bjd13626-cit-0052","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejca.2006.07.017","article-title":"Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy","volume":"43","author":"Casula","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.13626-BIB0053|bjd13626-cit-0053","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10689-007-9143-y","article-title":"BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma","volume":"6","author":"Monnerat","year":"2007","journal-title":"Fam Cancer"},{"key":"10.1111\/bjd.13626-BIB0054|bjd13626-cit-0054","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5","article-title":"Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours","volume":"25","author":"Ramus","year":"1999","journal-title":"Genes Chromosom Cancer"},{"key":"10.1111\/bjd.13626-BIB0055|bjd13626-cit-0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat Genet"},{"key":"10.1111\/bjd.13626-BIB0056|bjd13626-cit-0056","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archdermatol.2010.428","article-title":"Multiple primary cutaneous melanomas in Li-Fraumeni syndrome","volume":"147","author":"Curiel-Lewandrowski","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13626-BIB0057|bjd13626-cit-0057","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jmg.2003.016907","article-title":"Genetic susceptibility in familial melanoma from northeastern Italy","volume":"41","author":"Landi","year":"2004","journal-title":"J Med Genet"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13626","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13626","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13626\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T20:02:00Z","timestamp":1690747320000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/6\/1498\/6616112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13626","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}